Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 2. Hypotensive effects in normotensive and hypertensive rats

Journal of Cardiovascular Pharmacology
M KawakamiK Iwaki

Abstract

S-2150 is a new 1,5-benzothiazepine derivative possessing both calcium channel-blocking and alpha 1-adrenoceptor-blocking effects. In isolated rat thoracic aorta precontracted with KCl (18 mM), the 50% inhibitory concentration (IC50) value was 190 nM for S-2150, which was similar to that of diltiazem. In aorta precontracted with phenylephrine (0.3 microM), IC50 values of S-2150 and diltiazem were 29 nM and > 10 microM, respectively. The relative contribution of calcium channel-blocking and alpha 1-adrenoceptor-blocking activities to hypotension was determined by using anesthetized rats before and after masking of the alpha 1-receptors with prazosin. The hypotensive effect of S-2150 [0.3 and 1 mg/kg intravenously (i.v.)] was attenuated by 40% after prazosin treatment, whereas that of diltiazem was not. In conscious spontaneously hypertensive rats (SHRs), renal hypertensive rats, and normotensive rats, S-2150 [10, 30, and 60 mg/kg orally (p.o.)] caused dose-dependent hypotensive effects. The effect of S-2150 was 4-7 times more potent than that of diltiazem. There were no changes in the hypotensive effects with consecutive administration of S-2150 during 6-8 weeks in SHRs and stroke-prone SHRs (SHRSPs). In SHRSPs, S-2150 reduced t...Continue Reading

References

Dec 1, 1991·Trends in Pharmacological Sciences·G Zernig
Apr 1, 1988·Journal of Cardiovascular Pharmacology·H C StantonG S Poindexter
Jan 1, 1988·Annual Review of Pharmacology and Toxicology·D F Bohr, R C Webb
Sep 1, 1985·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·H NaritaT Morita
Jul 1, 1987·Journal of Pharmacological Methods·S MatsudaM Ueda
Jan 1, 1983·Circulation·G H BardyR E Ideker
Dec 1, 1993·Journal of Cardiovascular Pharmacology·H OkamuraM Kurokawa
Sep 1, 1994·Japanese Journal of Pharmacology·T KatoM Sakanashi
Mar 1, 1993·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·J L RodicioL M Ruilope

❮ Previous
Next ❯

Citations

Jul 22, 2008·European Journal of Medicinal Chemistry·Jitender B BariwalAnamik K Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.